Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery Against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis

Structure - United States
doi 10.1016/j.str.2017.07.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Ability to Inoculate Purified Malaria Sporozoites Will Accelerate Vaccine and Drug Discovery

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2014English

Structure of the Prolyl-tRNA Synthetase From the Eukaryotic pathogenGiardia Lamblia

Acta Crystallographica Section D Biological Crystallography
2012English

Evolution of Multiple, Mutually Orthogonal Prolyl-tRNA Synthetase/tRNA Pairs for Unnatural Amino Acid Mutagenesis in Escherichia Coli

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

New Chemotherapeutic Strategies Against Malaria, Leishmaniasis and Trypanosomiases

Current Medicinal Chemistry
Organic ChemistryBiochemistryDrug DiscoveryMolecular MedicinePharmacology
2013English

Analogs of Natural Aminoacyl-tRNA Synthetase Inhibitors Clear Malaria in Vivo

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

A New in Vivo Screening Paradigm to Accelerate Antimalarial Drug Discovery

PLoS ONE
Multidisciplinary
2013English

Drug Repositioning Can Accelerate Discovery of Pharmacological Chaperones

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2015English

Can Cloud-Based Tools Accelerate Alzheimer’s Disease Drug Discovery?

Expert Opinion on Drug Discovery
Drug Discovery
2016English

Aminoacyl-tRNA Synthetase

Science-Business eXchange
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy